Advanced Clinical Institute

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Alzheimer disease3 trials

Phase

• Phase 32 trials
• Phase 2/31 trial

Status

• Active, not recruiting1 trial
• Not yet recruiting1 trial
• Recruiting1 trial

Lead sponsor

• Annovis Bio Inc.2 trials
• Bristol-Myers Squibb1 trial

Running trials

• Not yet recruiting

  An Open-label Long-term Safety Study of Buntanetap in Participants With AD

  NCT07757204· Phase 2/3· Annovis Bio Inc.· Source

  Contact: Sherrie Bradley

• Recruiting

  A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)

  NCT06976203· Phase 3· Bristol-Myers Squibb· Source

  Contact: Mark Ornstein, Site 0075

• Active, not recruiting

  A Double-blind Dual Study Assessing Safety and Efficacy of Buntanetap in Participants With Early AD

  NCT06709014· Phase 3· Annovis Bio Inc.· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Alzheimer disease2 recruiting